IL-37 Ameliorates Renal Fibrosis by Restoring CPT1A-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease
Kidney Diseases · 2023 · 9 (2) · 104-117
DOI: 10.1159/000529460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney Diseases, online erschienen am 31.01.2023. Verfasst von Li Xiong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Cen…. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Diabetic kidney disease (DKD) is a major source of chronic kidney disease and end-stage renal disease. The injury of glomerulus in DKD is the primary focus; however, proximal tubulopathy also is an indispensable factor in the progression of DKD. Interleukin-37 (IL-37), an anti-inflammatory cytokine of IL-1 family member, has been demonstrated to be associated with diabetes and its relative complications in recent years, but the effect of IL-37 on renal fibrosis in DKD is unclear.
Methods
We established streptozotocin plus high fat diet-induced DKD mice model with wild type or IL-37 transgenic mice. Masson and HE staining, immunostaining, and Western blot were used to observe renal fibrosis. In addition, RNA-sequencing was applied to explore the potential mechanisms of IL-37. In vitro, treatment of human proximal tubular (HK-2) cells with 30 mmol/L high glucose or 300 ng/mL recombinant IL-37 further elucidated the possible mechanism of IL-37 inhibition of DKD renal fibrosis.
Results
In this work, we first verified the decreased expression of IL-37 in kidney of DKD patient and its correlation with clinical features of renal impairment. Moreover, IL-37 expression markedly attenuated proteinuria and renal fibrosis in DKD mice. Using RNA-sequencing, we found and confirmed a novel role of IL-37 in ameliorating fatty acid oxidation (FAO) reduction of renal tubular epithelial cells both in vivo and in intro. In addition, further mechanistic studies showed that IL-37 alleviated the FAO reduction in HK-2 cells and renal fibrosis in DKD mice through upregulating carnitine palmitoyl-transferase 1A (CPT1A), an important catalyzer for FAO pathway.
Conclusion
These data suggest that IL-37 attenuates renal fibrosis via regulating FAO in renal epithelial cells. Upregulation of IL-37 levels might be an effective therapeutic avenue for DKD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, The Key Laboratory for the Prevention and Treatment of Chronic Kidney Disease of Chongqing, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical Uni…
Zitieren
APA
Xiong, L., He, T., Liu, C., Qin, S., Xiao, T., Xin, W., Wang, Y., Ran, L., Zhang, B., & Zhao, J. (2023). IL-37 Ameliorates Renal Fibrosis by Restoring CPT1A-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease. Kidney Diseases, 9(2), 104-117. https://doi.org/10.1159/000529460
Vancouver
Xiong L, He T, Liu C, Qin S, Xiao T, Xin W, et al. IL-37 Ameliorates Renal Fibrosis by Restoring CPT1A-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease. Kidney Diseases. 2023;9(2):104-117. doi:10.1159/000529460
BibTeX
@article{Xiong2023,
author = {Xiong, Li and He, Ting and Liu, Chi and Qin, Shaozong and Xiao, Tangli and Xin, Wang and Wang, Yaqin and Ran, Li and Zhang, Bo and Zhao, Jinghong},
title = {IL-37 Ameliorates Renal Fibrosis by Restoring CPT1A-Mediated Fatty Acid Oxidation in Diabetic Kidney Disease},
journal = {Kidney Diseases},
year = {2023},
volume = {9},
number = {2},
pages = {104--117},
doi = {10.1159/000529460}
}
EUVIMED